Uncategorized

Who’s taking Ozempic? New data reveals ‘significant’ shift, prompts shortage fears – New York Post

Who’s taking Ozempic? New data reveals ‘significant’ shift, prompts shortage fears  New York Post GLP-1s Are Growing In Popularity As Weight Loss Drugs But Losing Steam Among Diabetics, Study Suggests  Forbes‘I need it. It’s annoying’: Diabetics frustrated by medication shortage  WGAL Susquehanna Valley Pa.As GLP-1 Demand Goes Up, Access and Coverage Go Down  MedscapeDiabetes patients search for answers as nationwide ‘diet drug’ shortage continues  KBTX